Michael Huber
Family Medicine · Lucedale, MSNPI 1487767281
Payments from drug & device makers
Across 140 payments — averaging $13.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$583
- Novo Nordisk$333
- Pfizer$235
- AbbVie$110
- Otsuka America Pharmaceutical, Inc.$105
- AstraZeneca$92
- plus $452 from 14 others
What the payments were for
- Food & beverage$1,86798%
- Education$432%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 34 | $583 |
| Novo Nordisk | 24 | $333 |
| Pfizer | 30 | $235 |
| AbbVie(2 entities) | 7 | $110 |
| Otsuka America Pharmaceutical, Inc. | 5 | $105 |
| AstraZeneca | 6 | $92 |
| GSK | 4 | $80 |
| Lilly USA, LLC | 5 | $69 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $59 |
| Amgen | 3 | $51 |
| Merck | 2 | $37 |
| Corcept Therapeutics | 2 | $29 |
| E.r. Squibb & Sons, L.L.C. | 2 | $25 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
| Insmed, Inc. | 1 | $16 |
| Exact Sciences | 1 | $14 |
| Boston Scientific | 1 | $13 |
| Genentech USA, Inc. | 1 | $12 |
| Astellas Pharma US Inc | 1 | $12 |
How this compares
$1,910 in reported general payments places this provider in the 65th percentile of 971 family medicine providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 137 | $149,670 |
| FarxigaDapagliflozin Propanediol | 205 | $132,999 |
| OzempicSemaglutide | 105 | $99,411 |
| EliquisApixaban | 126 | $74,335 |
| LinzessLinaclotide | 124 | $62,394 |
| MounjaroTirzepatide | 53 | $59,866 |
| Tresiba Flextouch U-200Insulin Degludec | 45 | $58,032 |
| XareltoRivaroxaban | 73 | $46,860 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 42 | $41,792 |
| TradjentaLinagliptin | 76 | $39,879 |
| JardianceEmpagliflozin | 47 | $36,311 |
| RybelsusSemaglutide | 14 | $27,834 |
| JanuviaSitagliptin Phosphate | 50 | $27,778 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 24 | $26,316 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 959 | $21,348 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $69 | $209,536190 claims |
| Novo NordiskOzempic, Rybelsus, Levemir, Tresiba | $333 | $144,164167 claims |
| AstraZenecaFarxiga, Symbicort | $92 | $138,807221 claims |
| AbbVieLinzess, Vraylar | $110 | $78,715136 claims |
| PfizerEliquis | $235 | $74,335126 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $80 | $57,70377 claims |
| MerckJanuvia | $37 | $27,77850 claims |
| Astellas Pharma US IncMyrbetriq | $12 | $12,26824 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 971 family medicine providers in Mississippi.
Other family medicine in Lucedale
- Paul MatherneGulfport$14.4M
- Timothy QuinnRidgeland$8M
- Sean KerbyGulfport$6.6M
- Rambod RouhbakhshHattiesburg$6M
- Randall HulingOlive Branch$4.6M
- Demetri MarshallPort Gibson$3M
- Alexander OsowaJackson$2.2M
- Russell CarlisleWesson$1.6M
- Kristi TrimmRidgeland$1.2M
- Keith StokesLexington$660K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.